|
Re: Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial
|
3
|
Zenith Epigenetics
|
Sep 03, 2018 12:50AM
|
|
Re: Zenith MD&A posted to SEDAR 8/23/18
|
5
|
Zenith Epigenetics
|
Sep 01, 2018 01:35PM
|
|
Failure of AZN's anifrolumab could be good for RVX
|
6
|
Resverlogix Corp.
|
Aug 31, 2018 03:57PM
|
|
Re: Blistering volume today
|
3
|
Resverlogix Corp.
|
Aug 30, 2018 03:43PM
|
|
Re: Private placement
|
6
|
Resverlogix Corp.
|
Aug 30, 2018 09:54AM
|
|
Re: Blistering volume today
|
2
|
Resverlogix Corp.
|
Aug 29, 2018 09:29PM
|
|
Blistering volume today
|
4
|
Resverlogix Corp.
|
Aug 29, 2018 01:51PM
|
|
Re: Resverlogix H2 2018 events
|
6
|
Resverlogix Corp.
|
Aug 29, 2018 12:53AM
|
|
Zenith/JNJ
|
5
|
Zenith Epigenetics
|
Aug 27, 2018 05:40PM
|
|
Re: Seeking Alpha post
|
1
|
Resverlogix Corp.
|
Aug 27, 2018 02:39PM
|
|
Re: Not predicting another short attack....
|
5
|
Resverlogix Corp.
|
Aug 23, 2018 02:20PM
|
|
Re: Many hands make light work....
|
3
|
Resverlogix Corp.
|
Aug 21, 2018 09:32PM
|
|
Re: Aureus
|
5
|
Resverlogix Corp.
|
Aug 20, 2018 01:25AM
|
|
Re: Eligibility for registered accounts in Canada
|
3
|
Zenith Epigenetics
|
Aug 19, 2018 09:07PM
|
|
Re: Eligibility for registered accounts in Canada
|
2
|
Zenith Epigenetics
|
Aug 19, 2018 01:18PM
|
|
Re: Got my voting instruction form in the mail....but
|
2
|
Resverlogix Corp.
|
Aug 17, 2018 11:59AM
|
|
Re: The meaning of 88
|
3
|
Resverlogix Corp.
|
Aug 17, 2018 11:52AM
|
|
Re: New shares issued?..where is everybody holding shares
|
1
|
Zenith Epigenetics
|
Aug 16, 2018 11:06PM
|
|
Re: Got my voting instruction form in the mail....but
|
1
|
Resverlogix Corp.
|
Aug 16, 2018 10:58PM
|
|
Re: ... time lines and yet to come...
|
4
|
Resverlogix Corp.
|
Aug 15, 2018 07:00PM
|
